| abstract |
Described herein are irreversible kinase inhibitor compounds exemplified by the following structure Formula (B2): n nmethods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of a B cell proliferative disorder or a mast cell proliferative disorder. |